Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Fibromun by Philogen for Leiomyosarcoma: Likelihood of Approval
Fibromun is under clinical development by Philogen and currently in Phase II for Leiomyosarcoma. According to GlobalData, Phase II drugs...
Fibromun by Philogen for Soft Tissue Sarcoma: Likelihood of Approval
Fibromun is under clinical development by Philogen and currently in Phase III for Soft Tissue Sarcoma. According to GlobalData, Phase...
Fibromun by Philogen for Malignant Glioma: Likelihood of Approval
Fibromun is under clinical development by Philogen and currently in Phase II for Malignant Glioma. According to GlobalData, Phase II...
Fibromun by Philogen for Glioblastoma Multiforme (GBM): Likelihood of Approval
Fibromun is under clinical development by Philogen and currently in Phase II for Glioblastoma Multiforme (GBM). According to GlobalData, Phase...
Fibromun by Philogen for Melanoma: Likelihood of Approval
Fibromun is under clinical development by Philogen and currently in Phase I for Melanoma. According to GlobalData, Phase I drugs...
Fibromun by Philogen for Malignant Glioma: Likelihood of Approval
Fibromun is under clinical development by Philogen and currently in Phase II for Malignant Glioma. According to GlobalData, Phase II...
Fibromun by Philogen for Glioblastoma Multiforme (GBM): Likelihood of Approval
Fibromun is under clinical development by Philogen and currently in Phase II for Glioblastoma Multiforme (GBM). According to GlobalData, Phase...
Fibromun by Philogen for Melanoma: Likelihood of Approval
Fibromun is under clinical development by Philogen and currently in Phase I for Melanoma. According to GlobalData, Phase I drugs...
Darleukin by Philogen for Melanoma: Likelihood of Approval
Darleukin is under clinical development by Philogen and currently in Phase I for Melanoma. According to GlobalData, Phase I drugs...
Fibromun by Philogen for Solid Tumor: Likelihood of Approval
Fibromun is under clinical development by Philogen and currently in Phase I for Solid Tumor. According to GlobalData, Phase I...
Teleukin by Philogen for Non-Small Cell Lung Cancer: Likelihood of Approval
Teleukin is under clinical development by Philogen and currently in Phase II for Non-Small Cell Lung Cancer. According to GlobalData,...
Dodekin by Philogen for Melanoma: Likelihood of Approval
Dodekin is under clinical development by Philogen and currently in Phase II for Melanoma. According to GlobalData, Phase II drugs...
Dodekin by Philogen for Non-Small Cell Lung Cancer: Likelihood of Approval
Dodekin is under clinical development by Philogen and currently in Phase II for Non-Small Cell Lung Cancer. According to GlobalData,...
Dodekin by Philogen for Triple-Negative Breast Cancer (TNBC): Likelihood of Approval
Dodekin is under clinical development by Philogen and currently in Phase II for Triple-Negative Breast Cancer (TNBC). According to GlobalData,...
Fibromun by Philogen for Liposarcoma: Likelihood of Approval
Fibromun is under clinical development by Philogen and currently in Phase III for Liposarcoma. According to GlobalData, Phase III drugs...